DotSpace Biomedical Inc.

DotSpace biomedical Inc. devoting their talents to provide of Medical Internet of Thing (MIoT) solutions, integrating hardware, software and database systems, and expanding from clinical intensive care to other clinical monitoring and health examinations. DotSpace biomedical Inc. is a preclinical-stage company taking a targeted approach in the development of realtime wireless intra-abdominal hypertension monitoring system to improve critical intensive care. We are delveloping a capsulized pressure sensor effectively transmit data in monitoring key intra-abdominal pressure and motility believed to be involved in acute pancreatitis, trauma, infection and inflammatory bowel disorders.

Two distinct, first-in-class devices have been developed that precisely detect gastrointestinal physiological changes—with minimal invasive process that has little side effects seen with other methods from this class. DotSpace biomedical Inc. is positioned to deliver a intra-abdominal monitoring system for FDA approval approximately 12 months after program funding, and their intention is to pursue integration in standard intensive care monitoring system.

CHIEN-HUNG LIAO
Founder

Nominated by

Professor and DBA Director,
Graduate Institute of Technology, Innovation & Intellectual Property Management, National Chengchi University
DotSpace Biomedical Inc. is a Taiwanese startup company found in 2021 by a group of medical doctors and researchers. DotSpace Biomedical Inc.’s main product “PressureDot” is a swallowing type intra-abdominal pressure measuring capsule system. This digital capsule developed using IoT communication technology can be used to detect the intra-abdominal pressure changes of critically ill patients, so that medical doctors can make correct surgical decisions in real time, thus patients with high-risk complications of abdominal cavity syndrome (ACS) can be treated one step earlier effectively.

“PressureDot” is the world first product of its kind, which is a breakthrough medical technology invention that will change the clinical practice and greatly increase the surgical success rate, as well as to maintain patients’ life quality.